ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC10407-5mg |
|
878141-96-9 |
S1RA
|
0 | C20H23N3O2 | |
GC10406-1mg |
|
238750-77-1 |
Tosedostat (CHR2797)
|
0 | C21H30N2O6 | |
GC10406-10mg |
|
238750-77-1 |
Tosedostat (CHR2797)
|
0 | C21H30N2O6 | |
GC10405-10mM (in 1mL DMSO) |
|
59-05-2 |
Methotrexate
|
0 | C20H22N8O5 | |
GC10405-500mg |
|
59-05-2 |
Methotrexate
|
0 | C20H22N8O5 | |
GC10405-200mg |
|
59-05-2 |
Methotrexate
|
0 | C20H22N8O5 | |
GC10405-100mg |
|
59-05-2 |
Methotrexate
|
0 | C20H22N8O5 | |
GC10404-1mg |
|
— |
PKC ζ pseudosubstrate
|
0 | C208H336N74O44S3 | |
GC10403-10mg |
|
321351-00-2 |
EO 1428
|
0 | C20H16BrClN2O | |
GC10403-5mg |
|
321351-00-2 |
EO 1428
|
0 | C20H16BrClN2O | |
GC10403-1mg |
|
321351-00-2 |
EO 1428
|
0 | C20H16BrClN2O | |
GC10402-50mg |
|
1619994-69-2 |
Bromosporine
|
0 | C17H20N6O4S | |
GC10402-10mg |
|
1619994-69-2 |
Bromosporine
|
0 | C17H20N6O4S | |
GC10402-5mg |
|
1619994-69-2 |
Bromosporine
|
0 | C17H20N6O4S | |
GC10401-10mg |
|
148688-01-1 |
SB 204070
|
0 | C19H27ClN2O4.HCl | |
GC10400-50mg |
|
459168-41-3 |
JNJ-7777120
|
0 | C14H16ClN3O | |
GC10400-10mg |
|
459168-41-3 |
JNJ-7777120
|
0 | C14H16ClN3O | |
GC10399-1g |
|
105462-24-6 |
Risedronate
|
0 | C7H11NO7P2 | |
GC10399-500mg |
|
105462-24-6 |
Risedronate
|
0 | C7H11NO7P2 | |
GC10399-100mg |
|
105462-24-6 |
Risedronate
|
0 | C7H11NO7P2 | |